UY29099A1 - Fenilaminotiazoles sustituidos y su uso - Google Patents
Fenilaminotiazoles sustituidos y su usoInfo
- Publication number
- UY29099A1 UY29099A1 UY29099A UY29099A UY29099A1 UY 29099 A1 UY29099 A1 UY 29099A1 UY 29099 A UY29099 A UY 29099A UY 29099 A UY29099 A UY 29099A UY 29099 A1 UY29099 A1 UY 29099A1
- Authority
- UY
- Uruguay
- Prior art keywords
- phenylaminotiazols
- substituted
- treatment
- diseases
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La presente solicitud se refiere a nuevos derivados de fenilaminotiazol, a procedimientos para su fabaricación, a su uso para el tratamiento y/o la profilaxis de enfermedades, así como a su uso para la fabricación de medicamentos para el tratamiento y/o la profilaxis de enfermedades, preferiblemente para el tratamiento y/o la prevención de hipertensión y otras enfermedades cardiovasculares.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004042607A DE102004042607A1 (de) | 2004-09-03 | 2004-09-03 | Substituierte Phenylaminothiazole und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29099A1 true UY29099A1 (es) | 2006-04-28 |
Family
ID=35852458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29099A UY29099A1 (es) | 2004-09-03 | 2005-09-05 | Fenilaminotiazoles sustituidos y su uso |
Country Status (24)
Country | Link |
---|---|
US (1) | US8691850B2 (es) |
EP (1) | EP1812430B1 (es) |
JP (1) | JP4999691B2 (es) |
KR (1) | KR20070057235A (es) |
CN (1) | CN101056875A (es) |
AR (1) | AR050551A1 (es) |
AT (1) | ATE428710T1 (es) |
AU (1) | AU2005281941A1 (es) |
BR (1) | BRPI0514833A (es) |
CA (1) | CA2578596C (es) |
DE (2) | DE102004042607A1 (es) |
EC (1) | ECSP077296A (es) |
ES (1) | ES2324049T3 (es) |
GT (1) | GT200500238A (es) |
IL (1) | IL181670A0 (es) |
MA (1) | MA28869B1 (es) |
MX (1) | MX2007002470A (es) |
NO (1) | NO20071343L (es) |
PE (1) | PE20060589A1 (es) |
SV (1) | SV2006002218A (es) |
TW (1) | TW200621765A (es) |
UY (1) | UY29099A1 (es) |
WO (1) | WO2006027142A1 (es) |
ZA (1) | ZA200701820B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006009813A1 (de) * | 2006-03-01 | 2007-09-06 | Bayer Healthcare Ag | Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel |
DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006044696A1 (de) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Ag | 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
DE102007061764A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
DE102008008838A1 (de) | 2008-02-13 | 2009-08-20 | Bayer Healthcare Ag | Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung |
DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
ES2428818T3 (es) * | 2008-05-29 | 2013-11-11 | Bayer Intellectual Property Gmbh | Dicianopiridinas sustituidas con 2-alcoxi y su uso |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
DE102009022894A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
IL280864B2 (en) | 2013-08-09 | 2024-03-01 | Ardelyx Inc | Compounds and methods for inhibiting phosphate transport |
WO2018153895A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit einem inhibitor der neutralen endopeptidase und/oder einem angiotensin ii rezeptor-antagonisten |
WO2018153897A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit hcn-kanal-hemmern |
WO2018153899A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit stimulatoren und/oder aktivatoren der löslichen guanylatcyclase (sgc) |
WO2018153898A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit mineralocorticoid-rezeptor-antagonisten |
WO2018153900A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit sglt-2-hemmern |
JP7323913B2 (ja) * | 2019-04-12 | 2023-08-09 | 国立大学法人 筑波大学 | 睡眠誘導剤である複素環化合物 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW299333B (es) | 1992-12-29 | 1997-03-01 | Takeda Pharm Industry Co Ltd | |
CN1056611C (zh) | 1994-06-16 | 2000-09-20 | 美国辉瑞有限公司 | 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体 |
JPH09132529A (ja) | 1995-11-09 | 1997-05-20 | Ono Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害剤 |
BR9707003A (pt) | 1996-01-17 | 1999-07-20 | Novo Nordisk As | Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto |
JPH10324687A (ja) | 1997-02-19 | 1998-12-08 | Nippon Soda Co Ltd | ピロール化合物、製法および農園芸用殺菌剤 |
JP2002507197A (ja) | 1997-05-30 | 2002-03-05 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換チオピリジン |
EP1000066A1 (en) | 1997-07-16 | 2000-05-17 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19947154A1 (de) | 1999-10-01 | 2001-10-04 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
BR0108611A (pt) | 2000-02-25 | 2003-05-06 | Hoffmann La Roche | Moduladores de receptor de adenosina |
MXPA03000436A (es) | 2000-07-18 | 2003-06-24 | Yamanouchi Pharma Co Ltd | Medicamentos que compreden derivados de dicianopiridina. |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
AU2002227243A1 (en) | 2000-12-11 | 2002-06-24 | E.I. Du Pont De Nemours And Company | Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests |
DE60117605T2 (de) | 2000-12-21 | 2006-12-07 | Bristol-Myers Squibb Co. | Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie |
DE10110438A1 (de) | 2001-03-05 | 2002-09-19 | Bayer Ag | Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10110747A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10110754A1 (de) | 2001-03-07 | 2002-09-19 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10115922A1 (de) | 2001-03-30 | 2002-10-10 | Bayer Ag | Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10134481A1 (de) | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
DE10238113A1 (de) | 2001-12-11 | 2003-06-18 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
JP2003183254A (ja) | 2001-12-20 | 2003-07-03 | Yamanouchi Pharmaceut Co Ltd | 2−アシルアミノ−3,5−ジシアノピリジン誘導体又はその塩 |
US7304061B2 (en) | 2002-04-26 | 2007-12-04 | Vertex Pharmaceuticals Incorporated | Heterocyclic inhibitors of ERK2 and uses thereof |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
EP1388342A1 (en) | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
US7186716B2 (en) | 2002-08-12 | 2007-03-06 | Sugen, Inc. | 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
WO2004054505A2 (en) | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
TWI270549B (en) | 2002-12-26 | 2007-01-11 | Taisho Pharmaceutical Co Ltd | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
JP4722851B2 (ja) | 2003-09-23 | 2011-07-13 | メルク・シャープ・エンド・ドーム・コーポレイション | キノリンカリウムチャネル阻害剤 |
AU2004289304A1 (en) | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Pyridine compounds |
US20050182105A1 (en) | 2004-02-04 | 2005-08-18 | Nirschl Alexandra A. | Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function |
JP2007161585A (ja) | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
DE102004032651A1 (de) | 2004-07-06 | 2006-02-16 | Bayer Healthcare Ag | Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen |
DE102006042143A1 (de) | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102008013587A1 (de) | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
-
2004
- 2004-09-03 DE DE102004042607A patent/DE102004042607A1/de not_active Withdrawn
-
2005
- 2005-08-30 WO PCT/EP2005/009316 patent/WO2006027142A1/de active Application Filing
- 2005-08-30 BR BRPI0514833-2A patent/BRPI0514833A/pt not_active IP Right Cessation
- 2005-08-30 ES ES05776232T patent/ES2324049T3/es active Active
- 2005-08-30 AU AU2005281941A patent/AU2005281941A1/en not_active Abandoned
- 2005-08-30 US US11/661,820 patent/US8691850B2/en not_active Expired - Fee Related
- 2005-08-30 DE DE502005007106T patent/DE502005007106D1/de active Active
- 2005-08-30 KR KR1020077007526A patent/KR20070057235A/ko not_active Application Discontinuation
- 2005-08-30 EP EP05776232A patent/EP1812430B1/de active Active
- 2005-08-30 MX MX2007002470A patent/MX2007002470A/es not_active Application Discontinuation
- 2005-08-30 AT AT05776232T patent/ATE428710T1/de not_active IP Right Cessation
- 2005-08-30 JP JP2007529331A patent/JP4999691B2/ja not_active Expired - Fee Related
- 2005-08-30 CN CNA2005800381572A patent/CN101056875A/zh active Pending
- 2005-08-30 CA CA2578596A patent/CA2578596C/en not_active Expired - Fee Related
- 2005-09-01 AR ARP050103664A patent/AR050551A1/es not_active Application Discontinuation
- 2005-09-01 GT GT200500238A patent/GT200500238A/es unknown
- 2005-09-02 PE PE2005001012A patent/PE20060589A1/es not_active Application Discontinuation
- 2005-09-02 SV SV2005002218A patent/SV2006002218A/es not_active Application Discontinuation
- 2005-09-02 TW TW094130123A patent/TW200621765A/zh unknown
- 2005-09-05 UY UY29099A patent/UY29099A1/es not_active Application Discontinuation
-
2007
- 2007-03-01 ZA ZA200701820A patent/ZA200701820B/xx unknown
- 2007-03-01 IL IL181670A patent/IL181670A0/en unknown
- 2007-03-02 EC EC2007007296A patent/ECSP077296A/es unknown
- 2007-03-13 NO NO20071343A patent/NO20071343L/no not_active Application Discontinuation
- 2007-03-23 MA MA29769A patent/MA28869B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP077296A (es) | 2007-04-26 |
PE20060589A1 (es) | 2006-08-12 |
JP2008511614A (ja) | 2008-04-17 |
NO20071343L (no) | 2007-05-30 |
IL181670A0 (en) | 2007-07-04 |
AR050551A1 (es) | 2006-11-01 |
GT200500238A (es) | 2006-04-10 |
TW200621765A (en) | 2006-07-01 |
SV2006002218A (es) | 2006-10-04 |
EP1812430A1 (de) | 2007-08-01 |
WO2006027142A1 (de) | 2006-03-16 |
DE102004042607A1 (de) | 2006-03-09 |
ATE428710T1 (de) | 2009-05-15 |
ES2324049T3 (es) | 2009-07-29 |
CA2578596A1 (en) | 2006-03-16 |
BRPI0514833A (pt) | 2008-06-24 |
US20080269300A1 (en) | 2008-10-30 |
CN101056875A (zh) | 2007-10-17 |
MA28869B1 (fr) | 2007-09-03 |
KR20070057235A (ko) | 2007-06-04 |
ZA200701820B (en) | 2008-08-27 |
AU2005281941A1 (en) | 2006-03-16 |
DE502005007106D1 (de) | 2009-05-28 |
US8691850B2 (en) | 2014-04-08 |
CA2578596C (en) | 2012-10-23 |
JP4999691B2 (ja) | 2012-08-15 |
EP1812430B1 (de) | 2009-04-15 |
MX2007002470A (es) | 2009-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP077296A (es) | Fenilaminotiazoles sustituidos y su uso | |
UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
AR058098A1 (es) | Derivados de acidos dicarboxilicos y su uso | |
ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
CR20140392A (es) | Dihidropirazolonas sustituidas | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
UY32497A (es) | "2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso" | |
UY30578A1 (es) | Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones | |
DOP2007000043A (es) | Derivados de cromanol sustituidos y su uso | |
DOP2006000062A (es) | Derivados de acido pirimidincarboxilico y su uso | |
GT200500266A (es) | Nuevos derivados de pirimidina y su uso | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
DOP2006000280A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
ECSP10010711A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
UY27733A1 (es) | Derivados de ciclopenteno. | |
DOP2005000174A (es) | Fenilaminotiazoles sustituidos y su uso | |
UY29247A1 (es) | Amidas de ácido pirazindicarboxílico y su uso | |
CR10449A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inihibidores de receptores de vasopresina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160530 |